You are here

  • Home
  • Archive
  • Volume 8, Issue 7
  • Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2–4 (SPACE trial)

Citation Tools

Article menu

Download PDFPDF

Neurology
Protocol
Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2–4 (SPACE trial)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Stam M, Wadman RI, Wijngaarde CA, et al
Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2–4 (SPACE trial)
BMJ Open 2018;8:e019932. doi: 10.1136/bmjopen-2017-019932